Document is current
Any future updates will be listed below
-
Authors
Park, Jiwoon
Kim, Junbum
Lewy, Tyler
Rice, Charles M.
Elemento, Olivier
Rendeiro, André F.
Mason, Christopher E. http://orcid.org/0000-0002-1850-1642
-
Funding
Funding for this research was provided by:
National Aeronautics and Space Administration (NNH18ZTT001N-FG2, 80NSSC22K0254)
Leukemia and Lymphoma Society (MCL7001-18, LLS 9238-16, LLS-MCL7001-18)
National Institute of Mental Health (R01MH117406)
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (R01AI158676, R01AI161444, R01AI151059)
Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA249054)
- License Information
-
More Information
Article History
Received: 6 May 2022
Accepted: 29 November 2022
First Online: 13 December 2022
Declarations
:
: C.E.M. is a scientific advisor of NanoString Inc. O.E. is scientific advisor and equity holder in Freenome, Owkin, Volastra Therapeutics and OneThree Biotech. The remaining authors declare no competing or relevant interests.
